Advertisement

Topics

A Quick Look at 2018 for ASCs

04:39 EST 8 Nov 2017 | AHC Media

What is the biggest issue ASCs will face in 2018? They will be challenged to sustain growth at a time when administrators are focused on lowering costs and raising quality during an era of mergers and acquisitions.

Original Article: A Quick Look at 2018 for ASCs

NEXT ARTICLE

More From BioPortfolio on "A Quick Look at 2018 for ASCs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...